Recanalization of arterial duct is feasible, effective and its potential risks are treatable

Acta Cardiologica
|July 4, 2015
PubMed

Insights

Arterial duct recanalization and stenting is a feasible and effective procedure for infants with pulmonary atresia needing improved pulmonary blood flow. Risks are manageable, but long-term studies are needed.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Recanalization of the arterial duct (AD) is a rare but sometimes necessary intervention.
  • This procedure is crucial for infants with congenital heart defects requiring improved pulmonary blood flow post-palliation.

Observation:

  • Three infants with pulmonary atresia (PA) and decreased pulmonary blood flow underwent AD recanalization and stenting.
  • Case 1: PA with intact ventricular septum, AD recanalization post-pulmonary valve intervention.
  • Case 2 & 3: PA with VSD, AD originating from the left subclavian artery, requiring recanalization after initial palliation and spontaneous closure, respectively. Complications included stent thrombosis (treated with thrombolysis) and transient bradycardia requiring resuscitation.

Findings:

  • Successful AD recanalization and stenting was achieved in all three infants.
  • All patients remained clinically stable during follow-up.
  • The procedure demonstrated feasibility and effectiveness in selected pediatric cases.

Implications:

  • Arterial duct recanalization and stenting is a viable option for select infants with complex congenital heart disease.
  • Potential risks associated with the procedure are treatable.
  • Further long-term studies are warranted to fully assess outcomes and durability.
Abstract